Statements (24)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:scientific_research_field
|
| gptkbp:aimsTo |
improve efficacy of CAR-T cell therapy
reduce side effects of CAR-T cell therapy |
| gptkbp:explores |
safety concerns
neurotoxicity solid tumors cytokine release syndrome manufacturing processes hematological malignancies target antigens |
| gptkbp:focusesOn |
gptkb:gene_therapy
|
| gptkbp:includes |
clinical trials
preclinical studies |
| gptkbp:publishedIn |
scientific journals
|
| gptkbp:relatedTo |
gptkb:immunotherapy
gptkb:cancer |
| gptkbp:studies |
chimeric antigen receptor T cells
|
| gptkbp:supportedBy |
academic institutions
government grants pharmaceutical companies |
| gptkbp:bfsParent |
gptkb:Genscript
gptkb:CD269 |
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
CAR-T cell therapy research
|